These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 28697169)

  • 1. Systemic Epstein-Barr Virus-positive T-Cell Lymphoproliferative Disease of Childhood With Good Response to Steroid Therapy.
    Kim DH; Kim M; Kim Y; Han K; Han E; Lee JW; Chung NG; Cho B
    J Pediatr Hematol Oncol; 2017 Nov; 39(8):e497-e500. PubMed ID: 28697169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic Epstein-Barr virus positive T-cell lymphoproliferative disease of childhood with hemophagocytic syndrome.
    Chen G; Chen L; Qin X; Huang Z; Xie X; Li G; Xu B
    Int J Clin Exp Pathol; 2014; 7(10):7110-3. PubMed ID: 25400806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two rare cases of Epstein-Barr virus-associated lymphoproliferative disorders in inflammatory bowel disease patients on thiopurines and other immunosuppressive medications.
    Subramaniam K; Cherian M; Jain S; Latimer M; Corbett M; D'Rozario J; Pavli P
    Intern Med J; 2013 Dec; 43(12):1339-42. PubMed ID: 24330365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic Epstein-Barr virus-positive T-cell lymphoproliferative disease presenting as a persistent fever and cough: a case report.
    Ameli F; Ghafourian F; Masir N
    J Med Case Rep; 2014 Aug; 8():288. PubMed ID: 25163591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The cutting-edge of medicine; Epstein-Barr virus associated lymphoproliferative disorders: disease concept and treatment].
    Suzuki R
    Nihon Naika Gakkai Zasshi; 2013 Apr; 102(4):979-85. PubMed ID: 23772516
    [No Abstract]   [Full Text] [Related]  

  • 6. Chronic active Epstein-Barr virus infection of T-cell type, systemic form in an African migrant: case report and review of the literature on diagnostics standards and therapeutic options.
    Wass M; Bauer M; Pfannes R; Lorenz K; Odparlik A; Müller LP; Wickenhauser C
    BMC Cancer; 2018 Oct; 18(1):941. PubMed ID: 30285657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic Epstein-Barr virus-positive T-cell lymphoproliferative disorders of childhood with fulminant leukocytosis and tumor lysis: a case report with autopsy findings.
    Wada S; Suzuki T; Kitazume K; Fujita A; Shimizu S
    Int J Hematol; 2018 Jul; 108(1):112-117. PubMed ID: 29218495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroa Vacciniforme-like Lymphoproliferative disorder in an adult invades the liver and bone marrow with clear pathological evidence: a case report and literature review.
    Wang X; Wang P; Wang A; Xu Y; Wang L; Chen Z
    BMC Infect Dis; 2021 Jan; 21(1):17. PubMed ID: 33407199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus polymerase chain reaction-negative stage IV post-transplant lymphoproliferative disorder in a heart transplant patient treated with rituximab.
    Garceau P; Couture C; Cantin B; Bernier V; Sénéchal M
    J Heart Lung Transplant; 2008 Aug; 27(8):928-31. PubMed ID: 18656811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FDG-PET/CT findings of chronic active Epstein-Barr virus infection.
    Toriihara A; Arai A; Nakadate M; Yamamoto K; Imadome KI; Miura O; Tateishi U
    Leuk Lymphoma; 2018 Jun; 59(6):1470-1473. PubMed ID: 29022747
    [No Abstract]   [Full Text] [Related]  

  • 11. Heterogeneity in clinical course of EBV-associated lymphoproliferative disorder after allogeneic stem cell transplantation.
    Meyer SC; Medinger M; Halter JP; Baldomero H; Hirsch HH; Tzankov A; Dirnhofer S; Passweg JR; Tichelli A
    Hematology; 2014 Jul; 19(5):280-5. PubMed ID: 24074746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-transplant lymphoproliferative disease and other Epstein-Barr virus diseases in allogeneic haematopoietic stem cell transplantation after introduction of monitoring of viral load by polymerase chain reaction.
    Kinch A; Oberg G; Arvidson J; Falk KI; Linde A; Pauksens K
    Scand J Infect Dis; 2007; 39(3):235-44. PubMed ID: 17366054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A distinct subtype of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorder: adult patients with chronic active Epstein-Barr virus infection-like features.
    Kawamoto K; Miyoshi H; Suzuki T; Kozai Y; Kato K; Miyahara M; Yujiri T; Choi I; Fujimaki K; Muta T; Kume M; Moriguchi S; Tamura S; Kato T; Tagawa H; Makiyama J; Kanisawa Y; Sasaki Y; Kurita D; Yamada K; Shimono J; Sone H; Takizawa J; Seto M; Kimura H; Ohshima K
    Haematologica; 2018 Jun; 103(6):1018-1028. PubMed ID: 29242302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus-positive mucocutaneous ulcer arising in a post-hematopoietic cell transplant patient followed by polymorphic posttransplant lymphoproliferative disorder and cytomegalovirus colitis.
    Satou A; Kohno A; Fukuyama R; Elsayed AA; Nakamura S
    Hum Pathol; 2017 Jan; 59():147-151. PubMed ID: 27569297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic EBV-positive lymphoproliferative disease of childhood.
    Portsmore S; Chakravorty S; Oppong E; Ahmad R; Bain BJ
    Am J Hematol; 2015 Apr; 90(4):355. PubMed ID: 25639946
    [No Abstract]   [Full Text] [Related]  

  • 16. Epstein-Barr virus-positive cytotoxic T-cell lymphoma followed by chronic active Epstein-Barr virus infection-associated T/NK-cell lymphoproliferative disorder: a case report.
    Kato S; Miyata T; Takata K; Shimada S; Ito Y; Tomita A; Elsayed AA; Takahashi E; Asano N; Kinoshita T; Kimura H; Nakamura S
    Hum Pathol; 2013 Dec; 44(12):2849-52. PubMed ID: 24012167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Favorable outcome of Epstein-Barr virus-associated B-cell lymphoproliferative disorder complicated by immunoglobulin G4-related disease treated with rituximab-based therapy: a case report.
    Ueda K; Ikeda K; Ogawa K; Sukegawa M; Sano T; Kimura S; Suzuki O; Hashimoto Y; Takeishi Y
    J Med Case Rep; 2016 Aug; 10(1):236. PubMed ID: 27557810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to rituximab-based therapy and risk factor analysis in Epstein Barr Virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.
    Styczynski J; Gil L; Tridello G; Ljungman P; Donnelly JP; van der Velden W; Omar H; Martino R; Halkes C; Faraci M; Theunissen K; Kalwak K; Hubacek P; Sica S; Nozzoli C; Fagioli F; Matthes S; Diaz MA; Migliavacca M; Balduzzi A; Tomaszewska A; Camara Rde L; van Biezen A; Hoek J; Iacobelli S; Einsele H; Cesaro S;
    Clin Infect Dis; 2013 Sep; 57(6):794-802. PubMed ID: 23771985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction.
    Omar H; Hägglund H; Gustafsson-Jernberg A; LeBlanc K; Mattsson J; Remberger M; Ringdén O; Sparrelid E; Sundin M; Winiarski J; Yun Z; Ljungman P
    Transpl Infect Dis; 2009 Oct; 11(5):393-9. PubMed ID: 19497070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr viral load before a liver transplant in children with chronic liver disease.
    Shakibazad N; Honar N; Dehghani SM; Alborzi A
    Exp Clin Transplant; 2014 Dec; 12(6):534-8. PubMed ID: 25489804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.